You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Claims for Patent: 10,849,849

✉ Email this page to a colleague

Summary for Patent: 10,849,849

Title:	Subcutaneous HER2 antibody formulations
Abstract:	Fixed dose HER2 antibody formulations for subcutaneous administration are provided along with their use in the treatment of cancer. The formulations include fixed dose subcutaneous formulations of pertuzumab and subcutaneous co-formulations of pertuzumab and trastuzumab, and their use in the treatment of cancer.
Inventor(s):	Eng-Wong Jennifer, Kirschbrown Whitney, Khan Tarik, Lin Jasper, Alavattam Sreedhara, Garg Amit, Heeson Sarah, Badovinac-Crnjevic Tanja, Wurth Christine
Assignee:
Application Number:	US15872648
Patent Claims:

Details for Patent 10,849,849

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Bausch & Lomb Incorporated	VITRASE	hyaluronidase	Injection	021640	May 05, 2004	⤷ Get Started Free	2038-01-16
Bausch & Lomb Incorporated	VITRASE	hyaluronidase	Injection	021640	December 02, 2004	⤷ Get Started Free	2038-01-16
Amphastar Pharmaceuticals, Inc.	AMPHADASE	hyaluronidase	Injection	021665	October 26, 2004	⤷ Get Started Free	2038-01-16
Akorn, Inc.	HYDASE	hyaluronidase	Injection	021716	October 25, 2005	⤷ Get Started Free	2038-01-16
Genentech, Inc.	PERJETA	pertuzumab	Injection	125409	June 08, 2012	⤷ Get Started Free	2038-01-16
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,849,849

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2018136412	⤷ Get Started Free
United States of America	2024269064	⤷ Get Started Free
United States of America	2023092354	⤷ Get Started Free
United States of America	2021085597	⤷ Get Started Free
United States of America	2018296470	⤷ Get Started Free
United States of America	11654105	⤷ Get Started Free
Ukraine	123292	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.